OTC Pharmaceuticals - Panama

  • Panama
  • Revenue in the OTC Pharmaceuticals market amounts to US$303.00m in 2024. The market is expected to grow annually by 7.86% (CAGR 2024-2029).
  • The market's largest segment is the segment Analgesics with a market volume of US$79.44m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$66.92 are generated in 2024.
  • In the OTC Pharmaceuticals market, 0.5% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Panama has experienced significant growth in recent years, driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the OTC Pharmaceuticals market in Panama have shifted towards self-medication and convenience.

Consumers are increasingly seeking over-the-counter medications for common ailments, such as cold and flu symptoms, allergies, and minor pain relief. This preference for self-medication is driven by a desire for immediate relief and cost savings, as over-the-counter medications are often more affordable than prescription drugs. Additionally, the convenience of being able to purchase these medications without a prescription or doctor's visit has also contributed to the growth of the OTC Pharmaceuticals market in Panama.

Trends in the market include the expansion of product offerings and the increasing availability of OTC Pharmaceuticals in various retail channels. Pharmacies and drugstores are the primary distribution channels for OTC Pharmaceuticals in Panama, but there has been a growing trend of these products being sold in supermarkets and convenience stores as well. This expansion of distribution channels has made OTC Pharmaceuticals more accessible to a wider range of consumers, further driving market growth.

Local special circumstances in Panama, such as a growing middle class and an aging population, have also contributed to the development of the OTC Pharmaceuticals market. As the middle class continues to expand, more individuals have disposable income to spend on healthcare products, including over-the-counter medications. Additionally, the aging population in Panama has led to an increased demand for OTC Pharmaceuticals for age-related ailments, such as arthritis and cardiovascular health.

Underlying macroeconomic factors, such as economic stability and government regulations, have also played a role in the growth of the OTC Pharmaceuticals market in Panama. The country's stable economy has provided a favorable environment for market expansion, attracting both domestic and international pharmaceutical companies to invest in the market. Furthermore, the government has implemented regulations to ensure the safety and efficacy of OTC Pharmaceuticals, which has built consumer trust and confidence in these products.

Overall, the OTC Pharmaceuticals market in Panama is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. With the continued growth of the middle class, increasing availability of OTC Pharmaceuticals, and favorable economic conditions, the market is expected to continue its upward trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)